The Technical Analyst
Select Language :
Centogene NV [CNTG]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

Centogene NV Price, Forecast, Insider, Ratings, Fundamentals & Signals

Centogene NV is listed at the  Exchange

2.10% €0.696

America/New_York / 28 mar 2024 @ 12:09


FUNDAMENTALS
MarketCap: 19.40 mill
EPS: -1.570
P/E: -0.440
Earnings Date: May 13, 2024
SharesOutstanding: 27.87 mill
Avg Daily Volume: 0.0376 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Neutral
Return On Equity: Neutral
Return On Asset: Buy
DE: Sell
P/E: Strong Buy
Price To Book: Neutral
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/a
Gr.Profitn/an/a
Ebitn/an/a
Asset n/an/a
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.440 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.02x
Company: PE -0.440 | industry: PE 18.71
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

€ 0.598 - 0.794

( +/- 14.07%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 12:19 - €0.704
Forecast 2: 13:09 - €0.707
Forecast 3: 13:49 - €0.690
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €0.696 (2.10% )
Volume 0.0178 mill
Avg. Vol. 0.0376 mill
% of Avg. Vol 47.26 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Centogene NV

Last 12 Months

Last 12 months chart data with high, low, open and close for Centogene NV

RSI

Last 10 Buy & Sell Signals For CNTG

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Centogene NV

CNTG

Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases and provide solutions that accelerate the development of orphan drugs. It provides various services, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. The company also offers COVID-19 testing solutions, including PCR and antigen testing services. It has collaboration and license agreements with Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Last 10 Buy Signals

Date Signal @
WIXMar 28 - 13:01$139.49
TGTXMar 28 - 13:01$15.38
USIGMar 28 - 13:01$50.81
TXGMar 28 - 13:01$38.11
TTDMar 28 - 13:01$87.81
MPWRMar 28 - 13:01$675.22
ASNDMar 28 - 13:01$146.65
STSOLUSDMar 28 - 12:59216.79
SYMMar 28 - 13:0045.22
MSOLUSDMar 28 - 12:58218.16

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.